In 2022, life sciences companies witnessed a sea of changes that brought both new challenges and opportunities. Goodwin helped, and continues to help, clients across the life sciences ecosystem navigate these stormy waters as they look for strategies to enhance research and development, optimize value from licensing, enter M&A and other transactions, and secure capital for growth.
This recap highlights the resilience of these industry-leading companies and the agility of our full-service, integrated global practice. We are continually inspired by our clients and look forward to our ongoing partnerships as we embrace 2023 and the evolving life sciences legal landscape.
By The Numbers
Our Global Recognition
Notable Deals
Counsel to Biocon Biologics in its $3.335 billion definitive agreement to acquire Viatris’ global biosimilars business.
Counsel to Nimbus Therapeutics in its sale to Takeda of Nimbus Lakshmi, Inc. and its tyrosine kinase 2 (Tyk2) inhibitor program for $6 billion.
Counsel to Blueprint Medicines in its transformative $1.25 billion strategic financing collaborations with Sixth Street and Royalty Pharma.
Counsel to Global Blood Therapeutics in its $5.4 billion sale to Pfizer.
Counsel to Forma Therapeutics on its $1.1 billion definitive agreement to be acquired by Novo Nordisk.
Counsel to Reviral on its $525 million definitive agreement to be acquired by Pfizer.
Counsel to BridgeBio Pharma on its $905 million exclusive licensing agreement with Bristol Myers Squibb.
Counsel to Syndesi Therapeutics in its $1 billion sale to AbbVie Central Finance B.V.
Counsel to Kelun-Biotech in its $9.3 billion exclusive collaboration and license agreement with Merck.
Dive Deeper With Goodwin
Learn More
Goodwin’s fully integrated Life Sciences practice helps clients navigate the industry’s rapidly evolving demands by serving as a “one-stop-shop” service, seamlessly advising through all stages of the corporate lifecycle and guiding our clients’ strategic and business goals.
We are proud to have a dedicated team of life sciences lawyers located in the major innovation hubs across the United States, Europe and Asia, giving our team the unique ability to advise clients when and where our services are needed.
Contacts
- /en/people/b/bloom-mitchell
Mitchell S. Bloom
PartnerChair, Life Sciences - /en/people/t/taft-kingsley
Kingsley L. Taft
PartnerCo-Chair, Life Sciences - /en/people/c/cable-stuart
Stuart M. Cable
Vice Chair & Global Head of M&A